THOC1 Polyclonal antibody 10920-1-AP proteintech

$149.00
In stock
SKU
10920-1-AP
Catalog No.SizePrice (USD)
10920-1-AP-20UL20 μL$149.00
10920-1-AP-150UL150 μL$449.00
Catalog Number10920-1-AP
SynonymsNuclear matrix protein p84, HPR1, p84N5, Tho 1, THO complex 1
HostRabbit
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, IP, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inHEK-293 cells
Tested Applications — Positive IP detected inHEK-293 cells
Tested Applications — Positive IHC detected inhuman colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inHeLa cells
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:1000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:20-1:200
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Positive WB detected inHEK-293 cells
Positive IP detected inHEK-293 cells
Positive IHC detected inhuman colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells
Western Blot (WB)WB : 1:500-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
Tested Reactivityhuman, mouse, rat
Cited Reactivityhuman, mouse, rat
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag1352 Product name: Recombinant human THOC1 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 291-657 aa of BC010381 Sequence: TGGEHVYFAKFLTSEKLMDLQLSDSNFRRHILLQYLILFQYLKGQVKFKSSNYVLTDEQSLWIEDTTKSVYQLLSENPPDGERFSKMVEHILNTEENWNSWKNEGCPSFVKERTSDTKPTRIIRKRTAPEDFLGKGPTKKILMGNEELTRLWNLCPDNMEACKSETREHMPTLEEFFEEAIEQADPENMVENEYKAVNNSNYGWRALRLLARRSPHFFQPTNQQFKSLPEYLENMVIKLAKELPPPSEEIKTGEDEDEEDNDALLKENESPDVRRDKPVTGEQIEVFANKLGEQWKILAPYLEMKDSEIRQIECDSEDMKMRAKQLLVAWQDQEGVHATPENLINALNKSGLSDLAESLTNDNETNS Predict reactive species
Full NameTHO complex 1
Calculated Molecular Weight84 kDa
Observed Molecular Weight84 kDa
GenBank Accession NumberBC010381
Gene SymbolTHOC1
Gene ID (NCBI)9984
RRIDAB_2202239
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDQ96FV9
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for THOC1 antibody 10920-1-APDownload protocol
IHC protocol for THOC1 antibody 10920-1-APDownload protocol
IP protocol for THOC1 antibody 10920-1-APDownload protocol
WB protocol for THOC1 antibody 10920-1-APDownload protocol
humanWB Cell Oncol (Dordr) Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA. Authors - Le Zhang View Article
mouseWB Elife Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells. Authors - Takashi Ogino View Article
Citations24
DilutionsWB : 1:500-1:1000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC : 1:20-1:200 IF/ICC : 1:50-1:500
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

THOC1 (THO complex subunit 1), also known as Tho1, P84, HPR1 or P84N5, is a 657 amino acid nuclear matrix protein and is evolutionarily conserved from yeast to humans. THOC1 contains one death domain and is a component of the heteromultimeric THO/TREX (transcription/export) complex along with THOC2, THOC3, BAT1 and ALY. The THO/TREX complex is recruited to transcribed genes and travels along with RNA polymerase II (Pol II) during elongation, coupling elongating Pol II with RNA splicing and export factors. THOC1 is expressed at high levels in breast cancer cells and at relatively low levels in normal epithelia. A reduction of THOC1 in cancer cell lines results in promoted cancer cell apoptosis and reduced cell proliferation. This suggests that cancer cells are dependent on the high levels of THOC1 expression and therefore THOC1 may be a good target for cancer therapy. This antibody recognizes the 84kd THOC1 protein. Protocols Product Specific Protocols IF protocol for THOC1 antibody 10920-1-AP Download protocol IHC protocol for THOC1 antibody 10920-1-AP Download protocol IP protocol for THOC1 antibody 10920-1-AP Download protocol WB protocol for THOC1 antibody 10920-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3Dpol protein via the ubiquitin-proteasome pathway
    Journal: J Med Virol | Authors: Chahui Tan | Species: human | Application: WB
  2. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Journal: Cancer Lett | Authors: Sai-Lan Liu | Species: human | Application: WB
  3. Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells.
    Journal: Elife | Authors: Takashi Ogino | Species: mouse | Application: WB
  4. Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis.
    Journal: Cancers (Basel) | Authors: Shaobo Huang | Species: human | Application: WB,IF
  5. Modulation of cell physiology by bispecific nanobodies enabling changes in the intracellular localization of organelle proteins
    Journal: Biochem Pharmacol | Authors: Akito Tsuruta | Application: WB
  6. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.
    Journal: Cell Oncol (Dordr) | Authors: Le Zhang | Species: human | Application: WB
  7. Modulation of cell physiology by bispecific nanobodies enabling changes in the intracellular localization of organelle proteins
    Journal: Biochem Pharmacol | Authors: Akito Tsuruta | Application: WB
  8. The suppression of thoc1 in cancer cell apoptosis mediated by activated macrophages is nitric oxide-dependent.
    Journal: Biochem Pharmacol | Authors: Lin Yong-Shiang YS | Species: mouse | Application: WB
  9. Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice
    Journal: Mol Cancer Res | Authors: Akito Tsuruta | Species: mouse | Application: WB
  10. Downregulation of BASP1 promotes temozolomide resistance in gliomas via epigenetic activation of the FBXO32/NF-κB/MGMT axis
    Journal: Mol Cancer Res | Authors: Xinyi Liao | Species: human | Application: WB
  11. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA.
    Journal: Cell Oncol (Dordr) | Authors: Le Zhang | Species: human | Application: WB
  12. Chemogenetic Activation of Oligodendrocytes Delays Postnatal Myelination by Promoting Progenitor Proliferation and Inhibiting Maturation.
    Journal: Glia | Authors: VT Cheli | Species: mouse | Application: WB
  13. Is Nrf2 Behind Endogenous Neuroprotection of the Hippocampal CA2-4,DG Region
    Journal: Mol Neurobiol | Authors: Anita Lewczuk | Species: rat | Application: WB
  14. TREX (transcription/export)-NP complex exerts a dual effect on regulating polymerase activity and replication of influenza A virus
    Journal: PLoS Pathog | Authors: Lingcai Zhao | Species: human | Application: WB,IF
  15. LincRNA01703 Facilitates CD81+ Exosome Secretion to Inhibit Lung Adenocarcinoma Metastasis via the Rab27a/SYTL1/CD81 Complex
    Journal: Cancers (Basel) | Authors: Yun Huang | Species: human | Application: WB
  16. Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis.
    Journal: Cancers (Basel) | Authors: Shaobo Huang | Species: human | Application: WB,IF
  17. N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of Jumonji and AT-rich interaction domain containing 2
    Journal: J Biol Chem | Authors: Takuto Inoki | Species: human | Application: WB
  18. Oncogenic accumulation of cysteine promotes cancer cell proliferation by regulating the translation of D-type cyclins
    Journal: J Biol Chem | Authors: Yumi Okano | Species: mouse | Application: WB
  19. Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancer
    Journal: J Biol Chem | Authors: Tomohito Tanihara | Species: mouse,human | Application: WB
  20. N-acetyltransferase 10 promotes glioblastoma malignancy via mRNA stabilization of Jumonji and AT-rich interaction domain containing 2
    Journal: J Biol Chem | Authors: Takuto Inoki | Species: human | Application: WB
  21. SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3Dpol protein via the ubiquitin-proteasome pathway
    Journal: J Med Virol | Authors: Chahui Tan | Species: human | Application: WB
  22. Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy
    Journal: Appl Biochem Biotechnol | Authors: Xiujuan Chen | Species: human | Application: WB
  23. Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer.
    Journal: Biochem Biophys Res Commun | Authors: Chenchen Liu | Species: human | Application: WB,IHC
  24. Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells.
    Journal: Elife | Authors: Takashi Ogino | Species: mouse | Application: WB

Reviews

Write Your Own Review
You're reviewing:THOC1 Polyclonal antibody 10920-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.